wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57493675-D8D0DE31-67B6-4B17-B1C4-521A4EE61079
Q57493675-D8D0DE31-67B6-4B17-B1C4-521A4EE61079
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57493675-D8D0DE31-67B6-4B17-B1C4-521A4EE61079
Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells
P2860
Q57493675-D8D0DE31-67B6-4B17-B1C4-521A4EE61079
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57493675-D8D0DE31-67B6-4B17-B1C4-521A4EE61079
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a10f7d07ce36d601d311d17efd6a833df534e441
P2860
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.